• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA时代的三阴性乳腺癌

Triple negative breast cancer in the era of miRNA.

作者信息

Sabit Hussein, Cevik Emre, Tombuloglu Huseyin, Abdel-Ghany Shaimaa, Tombuloglu Guzin, Esteller Manel

机构信息

Department of Genetics, Institute for Medical Research and Consultations, Imam Abdulrahman Bin Faisal University, P. O. Box: 1982, 31441, Dammam, Saudi Arabia.

Department of Genetics, Institute for Medical Research and Consultations, Imam Abdulrahman Bin Faisal University, P. O. Box: 1982, 31441, Dammam, Saudi Arabia.

出版信息

Crit Rev Oncol Hematol. 2021 Jan;157:103196. doi: 10.1016/j.critrevonc.2020.103196. Epub 2020 Dec 9.

DOI:10.1016/j.critrevonc.2020.103196
PMID:33307198
Abstract

The objective of this review is to elucidate the role of miRNAs in triple negative breast cancer (TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect, Springer, Web of Science and Scopus. We retrieved up to 1233 articles, based a rigorous selection criterion, only 197 articles were extensively reviewed. We selected articles only addressing TNBC, but not other types of breast cancer, with the employed approach being miRNA analysis and/or profiling. Our extensive review resulted in grouping of miRNAs into categories in which specific members of miRNAs have roles in specific mechanism in TNBC i.e., carcinogenesis, invasion, metastasis, apoptosis, diagnosis, prognosis, and treatment. TNBC is an aggressive subtype of breast cancer; therefore, different approaches for accurate diagnosis, prognosis and treatment are needed. In this review we summarize the up-to-date miRNA profiling, prognostic, and therapeutic findings that add to the route of controlling TNBC.

摘要

本综述的目的是阐明微小RNA(miRNA)在三阴性乳腺癌(TNBC)中的作用。为实现这一目标,我们检索了诸如PubMed、ScienceDirect、Springer、Web of Science和Scopus等数据库。我们共检索到1233篇文章,基于严格的筛选标准,仅对其中197篇文章进行了全面综述。我们仅选择了那些专门针对TNBC而非其他类型乳腺癌的文章,所采用的方法为miRNA分析和/或谱分析。我们的全面综述结果将miRNA分为不同类别,其中特定的miRNA成员在TNBC的特定机制中发挥作用,即致癌作用、侵袭、转移、凋亡、诊断、预后和治疗。TNBC是一种侵袭性乳腺癌亚型;因此,需要采用不同的方法进行准确的诊断、预后评估和治疗。在本综述中,我们总结了最新的miRNA谱分析、预后及治疗研究结果,这些结果为控制TNBC的途径增添了内容。

相似文献

1
Triple negative breast cancer in the era of miRNA.微小RNA时代的三阴性乳腺癌
Crit Rev Oncol Hematol. 2021 Jan;157:103196. doi: 10.1016/j.critrevonc.2020.103196. Epub 2020 Dec 9.
2
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.miRNAs 参与癌症发生、预后、治疗耐药及在三阴性乳腺癌中的应用
Cells. 2019 Nov 22;8(12):1492. doi: 10.3390/cells8121492.
3
Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer.揭示 microRNAs 在三阴性乳腺癌中的治疗策略和预后标志物作用。
Curr Pharm Biotechnol. 2020;21(15):1569-1575. doi: 10.2174/1389201021666200627201535.
4
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.miR-105/93-3p 促进化疗耐药,循环 miR-105/93-3p 可作为三阴性乳腺癌的诊断生物标志物。
Breast Cancer Res. 2017 Dec 19;19(1):133. doi: 10.1186/s13058-017-0918-2.
5
Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple‑negative breast cancer: An in silico study.鉴定与三阴性乳腺癌诊断和预后相关的失调 microRNAs:一项计算机研究。
Oncol Rep. 2019 Jun;41(6):3313-3324. doi: 10.3892/or.2019.7094. Epub 2019 Apr 2.
6
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.三阴性乳腺癌微环境中的新型 miRNA 靶点和治疗方法:一种具有挑战性疾病的新兴希望。
Int J Mol Sci. 2020 Nov 24;21(23):8905. doi: 10.3390/ijms21238905.
7
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.miR-629-3p可能作为三阴性乳腺癌肺转移的一种新型生物标志物和潜在治疗靶点。
Breast Cancer Res. 2017 Jun 19;19(1):72. doi: 10.1186/s13058-017-0865-y.
8
A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse.一个由八个 microRNAs 组成的面板是预测三阴性乳腺癌复发的一个很好的预测参数。
Theranostics. 2020 Jul 9;10(19):8771-8789. doi: 10.7150/thno.46142. eCollection 2020.
9
Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer.miRNA 在三阴性乳腺癌转移级联中的潜在作用
Curr Cancer Drug Targets. 2021;21(2):153-162. doi: 10.2174/1568009620999201103201626.
10
MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.微小RNA-455-3p通过靶向肿瘤抑制因子EI24促进三阴性乳腺癌的侵袭和迁移。
Oncotarget. 2017 Mar 21;8(12):19455-19466. doi: 10.18632/oncotarget.14307.

引用本文的文献

1
Multiplexed Single-Molecule Detection of Nucleic Acid Biomarkers with a Distance-Tuned Single FRET Pair.利用距离调谐单荧光共振能量转移对进行核酸生物标志物的多重单分子检测。
Anal Chem. 2025 Aug 23. doi: 10.1021/acs.analchem.5c01039.
2
Noncoding RNAs as regulators of FOSL1 in cancer.非编码RNA作为癌症中FOSL1的调节因子
Front Immunol. 2025 Aug 1;16:1599674. doi: 10.3389/fimmu.2025.1599674. eCollection 2025.
3
Regulatory Roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in Breast Cancer Progression.miR-155-5p、miR-21-5p、miR-93-5p和miR-140-5p在乳腺癌进展中的调控作用
Curr Issues Mol Biol. 2025 May 20;47(5):377. doi: 10.3390/cimb47050377.
4
Regulatory Effects of Extract, Known as Mountain Tea, on miRNA Expression and Its Pharmacokinetic Properties.名为山茶的提取物对miRNA表达及其药代动力学特性的调节作用。
Food Sci Nutr. 2025 May 25;13(6):e70341. doi: 10.1002/fsn3.70341. eCollection 2025 Jun.
5
Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects.三阴性乳腺癌中的细胞外囊泡:当前进展、挑战与未来展望
Front Mol Biosci. 2025 Apr 14;12:1561464. doi: 10.3389/fmolb.2025.1561464. eCollection 2025.
6
Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives.三阴性乳腺癌中的细胞外囊泡和基于微小RNA的疗法:进展与临床前景
Extracell Vesicles Circ Nucl Acids. 2025 Feb 14;6(1):54-71. doi: 10.20517/evcna.2024.85. eCollection 2025.
7
Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward.三阴性乳腺癌的放射影像学生物标志物:关于人工智能作用及未来发展方向的文献综述
BJR Artif Intell. 2024 Nov 13;1(1):ubae016. doi: 10.1093/bjrai/ubae016. eCollection 2024 Jan.
8
Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment.靶向三阴性乳腺癌中的NANOS1:地高辛与PD-1抑制剂在调节肿瘤免疫微环境中的协同作用
Front Oncol. 2025 Jan 24;14:1536406. doi: 10.3389/fonc.2024.1536406. eCollection 2024.
9
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.三阴性乳腺癌上皮-间质转化的靶向治疗方法
Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024.
10
Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.阐明肝细胞癌的进展:一种新的预后 miRNA-mRNA 网络和特征分析。
Sci Rep. 2024 Feb 29;14(1):5042. doi: 10.1038/s41598-024-55806-y.